CCRT improves survival in advanced NPC, induction chemo shows potential benefit
01 Nov 2019
byRoshini Claire Anthony
Concurrent chemoradiotherapy (CCRT) appeared to improve survival rates in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), according to a systematic review and meta-analysis, with a potential benefit noted with the addition of induction chemotherapy.
CCRT improves survival in advanced NPC, induction chemo shows potential benefit
01 Nov 2019